user avatar
ESCMID
@ESCMID
The European Society of Clinical Microbiology and Infectious Diseases Improving the diagnosis, treatment and prevention of infection-related diseases
Basel
Joined January 2010
  • user avatar
    We have another Agar Art winner from the #ECCMID2023 Art Gallery! Congrats to Ilvana Küçükkaya (Turkey) who won with her piece "Candida auris: Emerging into The World of Fungi" depicting C auris as the predator we know it is! We hope you enjoy your #ECCMID surprise box #ECCMIDart
  • user avatar
    Today is International Day of Women in Science so join us in saying THANK YOU! Thank you to all #WomenInScience, from the medical field, health sector, and more (especially clinical microbiology and infectious diseases!) who are on the frontlines of the global #COVID19 response.
    GIF
  • user avatar
    #ECCMID2022 in Lisbon has officially ended and we want to thank everyone who has made this return to onsite ECCMID such a success! We hope that you enjoyed your time and we can't wait to see you again next year in Copenhagen for #ECCMID2023!
  • user avatar
    The sun is setting on Copenhagen, Denmark and as the last #ECCMID2023 sessions end and we all depart, we want to say "THANK YOU" to everyone who came to participate and made our congress so successful this year! We can't wait to see you again next year in Barcelona, Spain!
  • user avatar
    ESCMID is teaming up with @IDSAInfo to host a breaking webinar on the recent outbreak of #Monkeypox across Europe and the US. Our experts will highlight a few cases before opening a round table discussion. Join us live on Tuesday 24 May at 12:00 CEST: ow.ly/BtjB50Je87y
  • user avatar
    Congrats to Alainna Jamal (@AlainnaJJ), one of our 30 under 30! She's an MD-PhD student at University of Toronto. She plans to combine research, clinical medicine, and leadership to improve the lives of patients. She wants to share our community’s research with a larger audience
  • user avatar
    ESCMID is very pleased to announce that it will be hosting a virtual congress specifically dedicated to #COVID19 . The ESCMID Conference on Corona Virus Disease (ECCVID) will take place online on 23-25 September 2020 and will cover all aspects of COVID-19. bit.ly/2AFp3Vb
  • user avatar
    We have just under 100 followers to go until we reach 33K! Our 33,000th follower will win a free #ECCMID2023 registration so be sure to follow and leave a like/retweet here to win! Good luck!
  • user avatar
    We received many outstanding abstracts this year for ECCMID and want to highlight all of the great research that has been done in our community. So we have just published our #ECCMID2020 Abstract Book. You can see them all here: bit.ly/3diKysL
  • user avatar
    It is our pleasure to invite you to the 31st ECCMID, which will take place from Friday, 9 July – Monday, 12 July 2021. We are very much looking forward to holding ECCMID next summer, in the sunny city of Vienna, Austria 🇦🇹
  • user avatar
    After very careful deliberation and consideration, a decision was taken today to now cancel the online portion of ECCMID 2020 as well. This decision was made with consideration of feedback received from registered participants, faculty members, service providers and sponsors. 1/7
  • user avatar
    #ECCMID2020 may be cancelled but the abstracts submitted were amazing so we're converting our Programme book into an Abstract book that's available May 5th! As we proceed we want to release a few preview abstracts to highlight them. Keep an eye out for those in the coming days!
  • user avatar
    🚨🚨DEADLINE EXTENDED! Abstract submission for #ECCMID2024 has been extended until this Friday, December 1st at 17:00 CET Get your finishing touches done and submit your research to be presented at #ECCMID! ow.ly/kspM50Qclf7
  • user avatar
    We are following COVID developments and can confirm there are no immediate plans to cancel or postpone #ECCMID2020. We are adhering to all guidelines set by the French Ministry of Health and WHO to ensure safety. See our statement and event updates here: bit.ly/2TjgGnL